"Analysis of cost-effectiveness has shown that albumin administration is also a cost-effective option. Given the difference in median charges for albumin...and for nonprotein colloids...albumin use results in approximately $52,000 to $54,000 in charges per life saved. This estimate compares favorably with a host of alternative uses of funds in coronary heart disease. Possible indirect savings are not taken into account."1
The table below demonstrates cost savings realized with albumin vs. hetastarch (HES). Because the price of albumin has decreased in recent years and varies among institutions, different published sources may present different prices. The price of albumin at your institution may be lower than that indicated below.
To calculate your own cost savings with albumin, use the convenient, interactive Cost-Savings Calculator.
The above information is provided as an example of potential cost savings. Actual cost savings may vary.
Reference
| 1. |
|
Sedrakyan A, Gondek K, Paltiel D, Elefteriades JA. Volume expansion with albumin decreases mortality after coronary artery bypass graft surgery. Chest. 2003;123(6):1853-1857. |
|